Characterization of replication-competent hepatitis A virus constructs containing insertions at the N terminus of the polyprotein

Journal of Virology

Volumn 72, Issue 1, 1998, Pages 349-357

  Zhang, Yuan ^a   Kaplan, Gerardo G ^a,b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; MONOCLONAL ANTIBODY; VIRUS VECTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; FETUS; GENE EXPRESSION; HEPATITIS A VIRUS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PICORNAVIRUS; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS HEPATITIS; VIRUS REPLICATION;

EID: 0031964592     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.1.349-357.1998     Document Type: Article

References (48)

1. Alexander, L., H. H. Lu, M. Gromeier, and E. Wimmer. 1994. Dicistronic polioviruses as expression vectors for foreign genes. AIDS Res. Hum. Retroviruses 10(Suppl. 2):S57-S60.
2. Allaire, M., M. M. Chernaia, B. A. Malcolm, and M. N. James. 1994. Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. Nature 369:72-76.
3. Altmeyer, R., N. Escriou, M. Girard, A. Palmenberg, and S. van der Werf. 1994. Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120. Proc. Natl. Acad. Sci. USA 91: 9775-9779.
4. Altmeyer, R., M. Girard, S. van der Werf, V. Mimic, L. Seigneur, and M. F. Saron. 1995. Attenuated mengovirus: a new vector for live recombinant vaccines. J. Virol. 69:3193-3196.
5. Anderson, D. A., and B. Ross. 1990. Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J. Virol. 64:5284-5289.
6. Anderson, M. J., D. C. Porter, P. N. Fultz, and C. D. Morrow. 1996. Poliovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIV(smm) PBj14. Virology 219:140-149.
7. Andino, R., D. Silvera, S. D. Suggett, P. L. Achacoso, C. J. Miller, D. Baltimore, and M. B. Feinberg. 1994. Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science 265:1448-1451.
8. Ansardi, D. C., Z. Moldoveanu, D. C. Porter, D. E. Walker, R. M. Conry, A. F. LoBuglio, S. McPherson, and C. D. Morrow. 1994. Characterization of poliovirus replicons encoding carcinoembryonic antigen. Cancer Res. 54: 6359-6364.
9. Ansardi, D. C., D. C. Porter, and C. D. Morrow. 1992. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. J. Virol. 66:4556-4563.
10. Arnold, G. F., D. A. Resnick, A. D. Smith, S. C. Geisler, A. K. Holmes, and E. Arnold. 1996. Chimeric rhinoviruses as tools for vaccine development and characterization of protein epitopes. Intervirology 39:72-78.
11. Belsham, G. J. 1992. Dual initiation of protein synthesis on foot-and-mouth disease virus RNA are selected following internal entry and scanning of ribosomes in vivo. EMBO J. 11:1105-1110.
12. Belsham, J. G., and N. Sonenberg. 1996. RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol. Rev. 60:499-511.
13. Bishop, N. E., and D. A. Anderson. 1993. RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus. Virology 197:616-623.
14. Brown, E. A., A. J. Zajac, and S. M. Lemon. 1994. In vitro characterization of an internal ribosomal entry site (IRES) present within the 5′ nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus. J. Virol. 68:1066-1074.
15. Burkot, T. R., Z. W. Da, H. M. Geysen, R. A. Wirtz, and A. Sau. 1991. Fine specificities of monoclonal antibodies against the Plasmodium falciparum circumsporozoite protein: recognition of both repetitive and non-repetitive regions. Parasite Immunol. 13:161-170.
16. Chow, M., J. F. Newman, D. J. Filman, J. M. Hogle, D. J. Rowlands, and F. Brown. 1987. Myristylation of picornaviruses capsid protein VP4 and its structural significance. Nature 327:482-486.
17. Cohen, J. I., J. R. Ticehurst, S. M. Feinstone, B. Rosenblum, and R. H. Purcell. 1987. Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J. Virol. 61:3035-3039.
18. Dedieu, J. F., J. Ronco, S. van der Werf, J. M. Hogle, Y. Henin, and M. Girard. 1992. Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1. J. Virol. 66:3161-3167.
19. Dotzauer, A., S. M. Feinstone, and G. Kaplan. 1994. Susceptibility of non-primate cell lines to hepatitis A virus infection. J. Virol. 68:6064-6068.
20. Evans, D. J., and J. W. Almond. 1991. Design, construction, and characterization of poliovirus antigen chimeras. Methods Enzymol. 203:386-400.
21. Francki, R. I. B., C. M. Fauquet, D. L. Knudson, and F. Brown. 1991 Classification and nomenclature of viruses. Arch. Virol. 2:320-326.
22. Gauss-Muller, V., F. Lottspeich, and F. Deinhardt. 1986. Characterization of hepatitis A virus structural proteins. Virology 155:732-736.
23. Gust, I. D., and S. M. Feinstone. 1988. Hepatitis A. CRC Press, Inc., Boca Raton, Fla.
24. Innis, B. L., R. Snitbhan, P. Kunasol, T. Laorakpongse, W. Poopatanakool, C. A. Kozik, S. Suntayakorn, T. Suknuntapong, A. Safary, D. B. Tang, and et al. 1994. Protection against hepatitis A by an inactivated vaccine. JAMA 271:1328-1334.
25. Jackson, R. J., S. L. Hunt, C. L. Gibbs, and A. Kaminski. 1994. Internal initiation of translation of picornavirus RNAs. Mol. Biol. Rep. 19:147-159.
26. Jia, X. Y., M. Tesar, D. F. Summers, and E. Ehrenfeld. 1996. Replication of hepatitis A viruses with chimeric 5′ nontranslated regions. J. Virol. 70:2861-2868.
27. Kaplan, G., M. S. Freistadt, and V. R. Racaniello. 1990. Neutralization of poliovirus by cell receptors expressed in insect cells. J. Virol. 64:4697-4702.
28. Kaplan, G., A. Totsuka, P. Thompson, T. Akatsuka, Y. Moritsugu, and S. M. Feinstone. 1996. Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 15:4282-4296.
29. Kusov, Y., Y. A. Kazachkov, G. K. Dzagurov, G. A. Khozinskaya, M. S. Balayan, and V. Gauss-Muller. 1992. Identification of precursors of structural proteins VP1 and VP2 of hepatitis A virus. J. Med. Virol. 37:220-227.
30. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
31. Le, S. Y., J. H. Chen, N. Sonenberg, and J. Maizel, Jr. 1993. Conserved tertiary structural elements in the 5′ nontranslaled region of cardiovirus, aphthovirus and hepatitis A virus RNAs. Nucleic Acids Res. 21:2445-2451.
32. MacGregor, A., M. Kornitschuk, J. G. Hurrell, N. I. Lehmann, A. G. Coulepis, S. A. Locarnini, and I. D. Gust. 1983. Monoclonal antibodies against hepatitis A virus. J. Clin. Microbiol. 18:1237-1243.
33. Malcolm, B. A., S. M. Chin, D. A. Jewell, J. R. Stratton-Thomas, K. B. Thudium, R. Ralston, and S. Rosenberg. 1992. Expression and characterization of recombinant hepatitis A virus 3C proteinase. Biochemistry 31:3358-3363.
34. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
35. Mattion, N. M., E. C. Harnish, J. C. Crowley, and P. A. Reilly. 1996. Foot-and-mouth disease virus 2A protease mediates cleavage in attenuated Sabin 3 poliovirus vectors engineered for delivery of foreign antigens. J. Virol. 70:8124-8127.
36. Mattion, N. M., P. A. Reilly, E. Camposano, S. L. Wu, S. J. DiMichele, S. T. Ishizaka, S. E. Fantini, J. C. Crowley, and C. Weeks-Levy. 1995. Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D. J. Virol. 69:5132-5137.
37. Mattion, N. M., P. A. Reilly, S. J. DiMichele, J. C. Crowley, and C. Weeks-Levy. 1994. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses. J. Virol. 68:3925-3933.
38. Miceli, R. M., M. E. DeGraaf, and H. D. Fischer. 1994. Two-stage selection of sequences from a random phage display library delineates both core residues and permitted structural range within an epitope. J. Immunol. Methods 167:279-287.
39. Porter, D. C., D. C. Ansardi, W. S. Choi, and C. D. Morrow. 1993. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection. J. Virol. 67:3712-3719.
40. Sangar, D. V., S. E. Newton, D. J. Rowlands, and B. E. Clarke. 1987. All foot-and-mouth disease virus serotypes initiate protein synthesis at two separate AUGs. Nucleic Acids Res. 15:3305-3315.
41. Schultheiss, T., W. Sommergruber, Y. Kusov, and V. Gauss-Muller. 1995. Cleavage specificity of purified reeombinant hepatitis A virus 3C proteinase on natural substrates. J. Virol. 69:1727-1733.
42. Sinnis, P., and B. L. Sim. 1997. Cell invasion by the vertebrate stages of Plasmodium. Trends Microbiol. 5:52-58.
43. Tesar, M., S. A. Harmon, D. F. Summers, and E. Ehrenfeld. 1992. Hepatitis A virus polyprotein synthesis initiates from two alternative AUG codons. Virology 186:609-618.
44. Tesar, M., X. Y. Jia, D. F. Summers, and E. Ehrenfeld. 1993. Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4. Virology 194:616-626.
45. Vaheri, A., and J. S. Pagano. 1965. Infectious poliovirus RNA: a sensitive method of assay. Virology 27:435-436.
46. Weitz, M., B. M. Baroudy, W. L. Maloy, J. R. Ticehurst, and R. H. Purcell. 1986. Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs. J. Virol. 60:124-130.
47. Werzberger, A., B. Mensch, B. Kuter, L. Brown, J. Lewis, R. Sitrin, W. Miller, D. Shouval, B. Wiens, G. Calandra, et al. 1992. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N. Engl. J. Med. 327:453-457.
48. Zhang, L., S. Sato, J. I. Kim, and R. P. Roos. 1995. Theiler's virus as a vector for foreign gene delivery. J. Virol. 69:3171-3175.